FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,019 | -79.0% | 240,575 | -52.8% | 0.00% | -66.7% |
| Q2 2023 | $2,426,662 | -41.5% | 509,803 | -29.9% | 0.00% | -50.0% |
| Q1 2023 | $4,146,676 | +48.6% | 727,487 | +163.0% | 0.01% | +50.0% |
| Q4 2022 | $2,790,531 | -100.0% | 276,564 | +3.5% | 0.00% | -60.0% |
| Q3 2022 | $5,987,459,000 | +126.4% | 267,178 | +150.3% | 0.01% | +150.0% |
| Q2 2022 | $2,645,215,000 | +56.8% | 106,748 | +145.3% | 0.00% | +100.0% |
| Q1 2022 | $1,687,464,000 | -58.9% | 43,525 | -38.0% | 0.00% | -66.7% |
| Q4 2021 | $4,105,120,000 | +116.0% | 70,161 | +118.8% | 0.01% | +100.0% |
| Q3 2021 | $1,900,670,000 | +73.4% | 32,068 | +154.0% | 0.00% | +200.0% |
| Q2 2021 | $1,095,811,000 | -2.5% | 12,626 | -7.4% | 0.00% | -50.0% |
| Q1 2021 | $1,124,453,000 | +5.0% | 13,638 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $1,070,519,000 | +59.5% | 11,773 | -29.9% | 0.00% | +100.0% |
| Q3 2020 | $671,136,000 | -82.9% | 16,791 | -85.3% | 0.00% | -85.7% |
| Q2 2020 | $3,920,569,000 | +499.4% | 114,269 | +288.0% | 0.01% | +600.0% |
| Q1 2020 | $654,129,000 | +370.5% | 29,452 | +314.6% | 0.00% | – |
| Q4 2019 | $139,025,000 | +3.3% | 7,104 | -18.1% | 0.00% | – |
| Q3 2019 | $134,630,000 | -1.5% | 8,669 | +28.8% | 0.00% | – |
| Q2 2019 | $136,680,000 | -38.3% | 6,733 | -46.6% | 0.00% | – |
| Q1 2019 | $221,417,000 | +744.7% | 12,602 | +683.2% | 0.00% | – |
| Q3 2018 | $26,211,000 | +43.7% | 1,609 | 0.0% | 0.00% | – |
| Q2 2018 | $18,246,000 | -81.0% | 1,609 | -83.6% | 0.00% | – |
| Q1 2018 | $95,843,000 | +66.5% | 9,820 | +4.2% | 0.00% | – |
| Q4 2017 | $57,575,000 | +290.7% | 9,423 | +153.2% | 0.00% | – |
| Q3 2017 | $14,735,000 | +13.8% | 3,721 | -6.9% | 0.00% | – |
| Q2 2017 | $12,950,000 | – | 3,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |